Tekla Healthcare Investors (HQH) Income Statement
HQH FY2025 at a glance
Fiscal year ended September 30, 2025 · U.S. dollarsHQH revenue and net income
Where HQH's revenue goes
FY2025Each bar shows an amount and its share of revenue. HQH kept 98.8% of revenue as net income.
HQH profit margins
HQH growth rates
to FY2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +826.8% | — | −16.3% | +36.9% |
| Gross profit | +826.8% | — | −16.3% | +36.9% |
| Operating income | — | — | −16.4% | — |
| Net income | −46.7% | — | −16.4% | +0.3% |
| EPS (diluted) | +3.1% | — | −27.5% | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
HQH quarterly EPS vs estimates
Tekla Healthcare Investors beat the analyst EPS estimate in 2 of the last 3 quarters.
HQH income statement
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $99.8M | $10.8M | $58.1M | $0 | $157.1M | $242.9M | $0 | $71.0M | $123.1M | $4.8M |
| Cost of revenue | $0 | $10.5M | $10.9M | $11.3M | $11.8M | $10.0M | $9.6M | $10.0M | $9.8M | $10.2M |
| Gross profit | $99.8M | $10.8M | $58.1M | −$192.3M | $157.1M | $242.9M | −$143.6M | $71.0M | $123.1M | $4.8M |
| Research & development | — | — | $1 | $3 | $2 | $3 | $2 | — | — | — |
| Sales, general & admin | $1.1M | $11.0M | $1.2M | $1.4M | $1.3M | $1.2M | $1.1M | $1.2M | $1.2M | $11.1M |
| Total operating expenses | $1.2M | $11.0M | $1.8M | $2.0M | $1.9M | $1.7M | $1.7M | $1.8M | $1.8M | $11.1M |
| Operating income | $98.6M | −$220,271 | $56.3M | −$194.2M | $155.2M | $241.2M | −$145.3M | $69.2M | $121.3M | −$6.3M |
| Interest income | $1.0M | $2.0M | $620,013 | $112,314 | $161.3M | $265,106 | $142.5M | $73.3M | $126.4M | $49.7M |
| Interest expense | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $49.7M |
| Income before taxes | $98.6M | $184.9M | $56.3M | −$194.2M | $155.2M | $241.2M | −$145.3M | $69.2M | $121.3M | −$56.0M |
| Income taxes | — | — | −$1.2M | −$3.7M | −$6.2M | −$2.0M | −$2.9M | −$161,141 | $0 | $0 |
| Net income | $98.6M | $184.9M | $56.3M | −$194.2M | $155.2M | $241.2M | −$145.3M | $69.2M | $121.3M | −$56.0M |
| EBITDA | $98.6M | — | $56.3M | −$190.6M | $161.4M | $243.2M | −$142.4M | $73.3M | $126.4M | −$49.7M |
| EPS (diluted) | $1.64 | $1.59 | $1.11 | −$4.12 | $5.14 | $8.20 | −$5.11 | $2.37 | $4.47 | −$2.28 |
| Gross margin | 100.0% | 100.0% | 100.0% | — | 100.0% | 100.0% | — | 100.0% | 100.0% | 100.0% |
| Operating margin | 98.8% | −2.0% | 96.9% | — | 98.8% | 99.3% | — | 97.5% | 98.6% | −130.9% |
| Net margin | 98.8% | 1,717.4% | 96.9% | — | 98.8% | 99.3% | — | 97.5% | 98.6% | −1,166.7% |
| Sep '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 | Sep '22 | Jun '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.0M | $5.5M | $5.5M | $5.3M | $2.7M | $4.7M | $75.2M | $5.6M | $25.2M | $4.3M | $56.1M | $4.0M |
| Cost of revenue | $5.1M | $0 | $0 | $0 | $5.2M | $0 | $5.4M | $0 | $5.5M | $0 | $5.4M | $0 |
| Gross profit | $11.9M | $5.5M | $5.5M | $5.3M | $2.7M | $4.7M | $69.8M | $5.6M | $19.7M | $4.3M | $50.7M | $4.0M |
| Sales, general & admin | — | $5.7M | $5.7M | $5.3M | $2.7M | $5.7M | $2.8M | $5.8M | $2.9M | $5.7M | $2.9M | $6.2M |
| Total operating expenses | −$161.5M | $5.7M | $5.7M | $5.3M | $2.7M | $5.7M | $15.7M | $5.8M | $38.8M | $5.7M | $41.7M | $6.2M |
| Operating income | $173.4M | −$189,149 | −$189,149 | −$31,122 | $99.7M | −$1.0M | −$26.8M | −$163,145 | $83.2M | −$1.4M | −$79.2M | −$2.2M |
| Income before taxes | $173.4M | $85.2M | $85.2M | $99.7M | $49.8M | −$26.8M | −$26.8M | $83.2M | $83.2M | −$79.2M | −$79.2M | −$115.0M |
| Income taxes | — | — | — | — | −$43,276 | $49.9M | −$1 | −$12.9M | $2 | $41.7M | −$2 | −$38.9M |
| Net income | $173.4M | $85.2M | $85.2M | $99.7M | $49.8M | −$26.8M | −$26.8M | $83.2M | $83.2M | −$79.2M | −$79.2M | −$115.0M |
| EBITDA | $173.4M | $561,413 | — | — | $99.7M | $49.9M | −$26.8M | −$81,572 | $83.2M | −$1.3M | −$79.2M | −$1.1M |
| EPS (diluted) | $3.03 | — | $1.59 | — | — | — | — | — | — | — | −$1.64 | — |
| Gross margin | 69.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 92.8% | 100.0% | 78.2% | 100.0% | 90.4% | 100.0% |
| Operating margin | 1,018.5% | −3.5% | −3.5% | −0.6% | 3,758.4% | −21.9% | −35.6% | −2.9% | 329.9% | −33.2% | −141.2% | −56.6% |
| Net margin | 1,018.5% | 1,560.2% | 1,560.2% | 1,879.2% | 1,879.2% | −575.2% | −35.7% | 1,477.7% | 329.9% | −1,835.0% | −141.2% | −2,908.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in HQH's financial statements (latest annual report filed September 30, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
HQH financial results
In fiscal year 2025 (ended September 30, 2025), Tekla Healthcare Investors reported revenue of $99.8 million, up 826.8% from the year before. It had net income of $98.6 million (down 46.7%), a net profit margin of 98.8%. Diluted earnings per share came to $1.64. Over five years revenue grew at an average rate of −16.3% a year.
See the HQH stock overview for the latest quote and news, or the HQH chart for price history and technical indicators.
HQH income statement FAQ
What is Tekla Healthcare Investors's annual revenue?
Tekla Healthcare Investors reported total revenue of $99.8 million for fiscal year 2025, which ended on September 30, 2025. That was up 826.8% from $10.8 million the previous year.
Is Tekla Healthcare Investors profitable?
Yes. Tekla Healthcare Investors reported net income of $98.6 million in fiscal 2025, a net profit margin of 98.8%; its operating margin was 98.8%.
What is Tekla Healthcare Investors's gross margin?
Tekla Healthcare Investors's gross margin was 100.0% in fiscal 2025: for every $100 of revenue, Tekla Healthcare Investors kept $100 after the direct cost of its products and services.
How fast is Tekla Healthcare Investors growing?
Revenue grew −16.3% a year on average over the last five fiscal years, from $242.9 million to $99.8 million.
What are Tekla Healthcare Investors's earnings per share?
Tekla Healthcare Investors earned $1.64 per diluted share in fiscal 2025, compared with $1.59 a year earlier.
When does Tekla Healthcare Investors's fiscal year end?
Tekla Healthcare Investors's fiscal year ends in September. The latest annual report covers the year ended September 30, 2025 and was filed on September 30, 2025.